2 views left Get unlimited views with a free account

Subscribe to GlobalData Explorer

Explore the latest trends and actionable insights on the Meningioma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Meningioma by Phase

Industry: Pharmaceuticals
Current: Other Industry Indicators

There are currently 32 ongoing clinical trials involving Meningioma
Of the 32 trials,19 trials are in Phase II
Furthermore, 7 trials are in Phase I

Number of ongoing Clinical Trials (for drugs) involving Meningioma by Phase

View as table

The global pharmaceutical industry is steadily developing new drugs for Meningioma, an Oncology disorder. The largest number of ongoing clinical trials for Meningioma is conducted in North America. Asia-Pacific and Europe are among some of the other prominent regions engaged in Meningioma -related drug trials.

Keio University School of Medicine: The leading ongoing Meningioma related clinical trial sponsor

Keio University School of Medicine is the top sponsor for Meningioma-related ongoing clinical trials.

Beijing Tiantan Hospital Capital Medical University, University of Iowa, and Massachusetts General Hospital are among other notable clinical trial sponsors involved in Meningioma. A clinical trial sponsor can be a Company, Government, Individual, or Institution.

Explore the latest trends and actionable insights on the Meningioma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Explore the latest trends and actionable insights on the Meningioma Pipeline Drugs to inform business strategy and pinpoint opportunities and risks. Visit Report Store